Parkinson Disease Clinical Trial
Official title:
A Study to Determine Whether the Daily Consumption of Flavonoid-rich Pure Cocoa Can Reduce Fatigue in People With Parkinson's (PD)
This study determines to evaluate the effectiveness of the daily consumption of flavonoid-rich cocoa in the treatment of fatigue in Parkinson's patients. The participants were divided equally between the flavonoid-rich cocoa (device) and control cocoa groups. The participant will engage in a six day trial, with measures taken at Day 1 and Day 6.
Many pwPD have expressed their interest in dietary therapies to manage their symptoms;
however scientific evidence for these therapies is lacking. Flavonoids, plant compounds found
in certain foods, may have the ability to improve fatigue. However, to date, no well-designed
intervention studies assessing the role of flavonoid consumption for fatigue management in
pwPD have been performed.
The aim of this project is to undertake a feasibility preliminary study to determine whether
flavonoid-rich cocoa has the potential to improve fatigue in pwPD in order to inform a follow
on trial. Participants will be recruited from the European Parkinson Therapy Centre (EPTC)
and will be those about to enrol onto the 6 day program. They will be required to consume a
cocoa drink each morning for 6 days. They will have measures taken including fatigue measures
using visual rating scales, walking tests and several questionnaires will be administered
during this time.
Aims:
The hypothesis is that the consumption of a flavonoid-rich pure cocoa beverage will reduce
fatigue in pwPD. The aim of this study is to determine the feasibility of a trial to evaluate
this proposal.
Design:
This is a randomised double-blind placebo controlled feasibility study in which 20 (+
potentially 20 more if adherence is acceptable and recruitment is progressing as expected)
pwPD will be recruited from the European Parkinson Therapy Centre (EPTC), Italy.
Intervention:
A 6 day nutrition intervention period, with a total of 2 assessments (baseline and day 6)
where outcome measures will be assessed.
Population:
20 men and women with a diagnosis of PD and who are over 18 years of age. There will be 10
participants in each trial arm.
Outcome Measures:
In order to assess benefits, a range of outcomes will be obtained. Outcome measures include:
Levels of physical activity: wearable activity monitors (worn like a watch)
Dietary patterns: 2-24 hour dietary record
Fatigue levels: Fatigue Severity Scale (FSS) and during the intervention the numerical rating
scale (NRS) 3 times daily
Fatigability: performance on 6 minute walk test (physical) and AMIPB cognitive test
Health descriptives: basic health questionnaire, Euroqol (EQ5DVAS), SF36 Health survey,
Unified Parkinson's Disease Rating Scale non motor symptoms (UPDRSNMS), routinely
administered to the centre by Trescore Hospital.
Duration and follow-up:
Participants will be consented by a trained researcher at the Centre and, if successfully
pass the eligibility check will be enrolled into the study. Staff at the Centre will be
trained on taking consent by researchers at OBU. Once a participant is enrolled, a baseline
assessment (Assessment 1) will be conducted at day 1. Immediately following completion of
Assessment 1, participants will be randomly allocated to either the high flavonoid
intervention group or the control group, and intervention delivery will begin immediately
after allocation. They will be reassessed at day 6. Those in the control group will follow
the same procedure, the only difference being that they receive the low flavonoid drink. Alex
Reed and the EPTC will inform participant GPs about their involvement in the study.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05415774 -
Combined Deep Brain Stimulation in Parkinson's Disease
|
N/A | |
Recruiting |
NCT04691661 -
Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease
|
Phase 2 | |
Active, not recruiting |
NCT05754086 -
A Multidimensional Study on Articulation Deficits in Parkinsons Disease
|
||
Completed |
NCT04045925 -
Feasibility Study of the Taïso Practice in Parkinson's Disease
|
N/A | |
Recruiting |
NCT04194762 -
PARK-FIT. Treadmill vs Cycling in Parkinson´s Disease. Definition of the Most Effective Model in Gait Reeducation
|
N/A | |
Completed |
NCT02705755 -
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
|
Phase 2 | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT05830253 -
Free-living Monitoring of Parkinson's Disease Using Smart Objects
|
||
Recruiting |
NCT03272230 -
Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System
|
N/A | |
Recruiting |
NCT06139965 -
Validity and Reliability of the Turkish Version of the Comprehensive Coordination Scale in Parkinson's Patients
|
||
Completed |
NCT04580849 -
Telerehabilitation Using a Dance Intervention in People With Parkinson's Disease
|
N/A | |
Completed |
NCT04477161 -
Effect of Ketone Esters in Parkinson's Disease
|
N/A | |
Completed |
NCT03980418 -
Evaluation of a Semiconductor Camera for the DaTSCAN™ Exam
|
N/A | |
Completed |
NCT04942392 -
Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic
|
N/A | |
Terminated |
NCT03446833 -
LFP Beta aDBS Feasibility Study
|
N/A | |
Completed |
NCT03497884 -
Individualized Precise Localization of rTMS on Primary Motor Area
|
N/A | |
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Recruiting |
NCT04997642 -
Parkinson's Disease and Movement Disorders Clinical Database
|
||
Completed |
NCT04117737 -
A Pilot Study of Virtual Reality and Antigravity Treadmill for Gait Improvement in Parkinson
|
N/A | |
Recruiting |
NCT03618901 -
Rock Steady Boxing vs. Sensory Attention Focused Exercise
|
N/A |